Sarepta Therapeutics Inc (NASDAQ: SRPT) stock closed at $130.50 on 11/26/24 after a major increase of 13.8%. Moreover, trading volume in this advance was exceptionally high at 344% of normal. The stock has risen 24.7% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Sarepta Therapeutics has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Sarepta Therapeutics has a very high Appreciation Score of 92 but a slightly negative Power Rating of 33, producing the High Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment